Paper36926608
Antiviral Potential of the Genus Panax: An updated review on their effects and underlying mechanism of action.
Zhang Y and 4 others. J Ginseng Res, 2023. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Antiviral Potential of the Genus Panax: An updated review on their effects and underlying mechanism of action. Papers, record 36926608. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36926608
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antiviral Potential of the Genus Panax: An updated review on their effects and underlying mechanism of action.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References96
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31695572 | Korean Red Ginseng increases defective pol gene in peripheral blood mononuclear cells of HIV-1-infected patients; inhibition of its detection during ginseng-based combination therapy. | J Ginseng Res | 2019 | https://conductscience.org/library/papers/31695572 | PubMed |
| 2 | 26869820 | Chemical diversity of ginseng saponins from Panax ginseng. | J Ginseng Res | 2015 | https://conductscience.org/library/papers/26869820 | PubMed |
| 3 | 18676527 | Safety and tolerability of North American ginseng extract in the treatment of pediatric upper respiratory tract infection: a phase II randomized, controlled trial of 2 dosing schedules. | Pediatrics | 2008 | https://conductscience.org/library/papers/18676527 | PubMed |
| 4 | 28652073 | Antiviral Strategies against PRRSV Infection. | Trends Microbiol | 2017 | https://conductscience.org/library/papers/28652073 | PubMed |
| 5 | 26494167 | Aquatic viruses induce host cell death pathways and its application. | Virus Res | 2016 | https://conductscience.org/library/papers/26494167 | PubMed |
| 6 | 9717216 | Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis. | Trends Microbiol | 1998 | https://conductscience.org/library/papers/9717216 | PubMed |
| 7 | 23717160 | Protective effect of ginsenoside-Rb2 from Korean red ginseng on the lethal infection of haemagglutinating virus of Japan in mice. | J Ginseng Res | 2013 | https://conductscience.org/library/papers/23717160 | PubMed |
| 8 | 32032764 | Grass carp reovirus VP56 represses interferon production by degrading phosphorylated IRF7. | Fish Shellfish Immunol | 2020 | https://conductscience.org/library/papers/32032764 | PubMed |
| 9 | 30200514 | Antiviral Activity of Fermented Ginseng Extracts against a Broad Range of Influenza Viruses. | Viruses | 2018 | https://conductscience.org/library/papers/30200514 | PubMed |
| 10 | 1835211 | Mystery swine disease in The Netherlands: the isolation of Lelystad virus. | Vet Q | 1991 | https://conductscience.org/library/papers/1835211 | PubMed |
| 11 | 28958807 | Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development. | Vaccine | 2019 | https://conductscience.org/library/papers/28958807 | PubMed |
| 12 | 30176393 | Ultra-sonication-assisted silver nanoparticles using Panax ginseng root extract and their anti-cancer and antiviral activities. | J Photochem Photobiol B | 2018 | https://conductscience.org/library/papers/30176393 | PubMed |
| 13 | 22688124 | Protective effects of 20(s)-protopanaxtriol on viral myocarditis infected by coxsackievirus B3. | Pathobiology | 2012 | https://conductscience.org/library/papers/22688124 | PubMed |
| 14 | 30156344 | Rotavirus: Genetics, pathogenesis and vaccine advances. | Rev Med Virol | 2018 | https://conductscience.org/library/papers/30156344 | PubMed |
| 15 | 30345002 | Recent advances in understanding rhinovirus immunity. | F1000Res | 2018 | https://conductscience.org/library/papers/30345002 | PubMed |
| 16 | 24004833 | Stimulation of TRAF6/TAK1 degradation and inhibition of JNK/AP-1 signalling by ginsenoside Rg3 attenuates hepatitis B virus replication. | Int J Biochem Cell Biol | 2013 | https://conductscience.org/library/papers/24004833 | PubMed |
| 17 | 30934919 | Hepatitis C Virus Non-Structural Protein 5A (NS5A) Disrupts Mitochondrial Dynamics and Induces Mitophagy. | Cells | 2019 | https://conductscience.org/library/papers/30934919 | PubMed |
| 18 | 29021696 | Antiviral activity of 20(R)-ginsenoside Rh2 against murine gammaherpesvirus. | J Ginseng Res | 2017 | https://conductscience.org/library/papers/29021696 | PubMed |
| 19 | 28052637 | Future anti-HBV strategies. | Liver Int | 2017 | https://conductscience.org/library/papers/28052637 | PubMed |
| 20 | 32980486 | Ginsenoside Rb1 is an immune-stimulatory agent with antiviral activity against enterovirus 71. | J Ethnopharmacol | 2021 | https://conductscience.org/library/papers/32980486 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42075153 | Ginsenoside Rh1 Suppresses Vesicular Stomatitis Virus Replication by Inhibiting Autophagy to Promote Immune Responses. | Microorganisms | 2026 | https://conductscience.org/library/papers/42075153 | PubMed |
| 41328325 | Discovery of a Novel Non-Nucleoside Inhibitor of RNA-Dependent RNA Polymerase Against Dengue Virus. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/41328325 | PubMed |
| 41011811 | Balancing Host Defense and Viral Tolerance for the Development of Next-Generation Broad-Spectrum Antiviral Agents. | Pathogens | 2025 | https://conductscience.org/library/papers/41011811 | PubMed |
| 40141242 | Anti-Colorectal Cancer Activity of Panax and Its Active Components, Ginsenosides: A Review. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40141242 | PubMed |
| 39988791 | Modulating nasal barrier function and tissue remodeling in inflammatory diseases: the role of ginseng and its bioactive compounds. | Tissue Barriers | 2025 | https://conductscience.org/library/papers/39988791 | PubMed |
| 39640799 | Chinese medicine in the treatment of chronic hepatitis B: The mechanisms of signal pathway regulation. | Heliyon | 2024 | https://conductscience.org/library/papers/39640799 | PubMed |
| 39590322 | The Adaptive Mechanism of Ginseng Rhizomes in Response to Habitat Changes. | Curr Issues Mol Biol | 2024 | https://conductscience.org/library/papers/39590322 | PubMed |
| 39588153 | Changes in the chemical composition and medicinal effects of black ginseng during processing. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39588153 | PubMed |
| 39583165 | Effects of Korean Red Ginseng combination therapy on HIV-infected patients treated with integrase strand transfer inhibitors. | J Ginseng Res | 2024 | https://conductscience.org/library/papers/39583165 | PubMed |
Genes34
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36926608
GET https://conductscience.org/api/papers/v1/36926608/references?page=2